Anja Vogelmann

Development of First-in-Class Dual Sirt2/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin Deacetylation

Laura Sinatra, Anja Vogelmann, F Friedrich et al. · Journal of Medicinal Chemistry · 2023 · 29 citations · Full text

Development of a NanoBRET assay to validate inhibitors of Sirt2-mediated lysine deacetylation and defatty-acylation that block prostate cancer cell migration

Anja Vogelmann, Matthias Schiedel, Nathalie Wössner et al. · RSC Chemical Biology · 2022 · 25 citations · Full text

Comparison of Cellular Target Engagement Methods for the Tubulin Deacetylases Sirt2 and HDAC6: NanoBRET, CETSA, Tubulin Acetylation, and PROTACs

Anja Vogelmann, Manfred Jung, Finn K. Hansen et al. · ACS Pharmacology & Translational Science · 2022 · 16 citations · Full text

Small Molecule Inhibitors, Tubulin Acetylation, Molecular Biology +22

Proteolysis-Targeting Chimeras (PROTACs) Based on Macrocyclic Tetrapeptides Selectively Degrade Class I Histone Deacetylases 1–3

Martin Roatsch, Anja Vogelmann, Daniel Herp et al. · 2020 · 14 citations · Full text

Histone Deacetylases, Molecular Biology, Peptide Science +19

Syntheses of Thailandepsin B Pseudo‐Natural Products: Access to New Highly Potent HDAC Inhibitors via Late‐Stage Modification

Jana Brosowsky, Monika Lutterbeck, Amelie Liebich et al. · Chemistry - A European Journal · 2020 · 13 citations · Full text